Patent · US Active

Use of modified cells for the treatment of multiple sclerosis

US8673293B2 · kind B2 · utility

23Cited by

0References

14Claims

0Family size

Assignee

Universitat Zurich · CH

Inventors

Roland Martin · Hamburg, DE
Andreas Lutterotti · Mils, AT
Stephen D. Miller · Marion, US

Key dates

Filing date	Oct 31, 2008
Grant date	Mar 18, 2014
Priority date	—
Expiry date	Jun 27, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/70503
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention describes blood cells chemically coupled with immunodominant myelin peptides and their use in the treatment of Multiple Sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.